Skip to main content
INTERCEDE GROUP PLC logo

INTERCEDE GROUP PLC — Investor Relations & Filings

Ticker · IGP ISIN · GB0003287249 LEI · 2138001HHZHVUMKZ8968 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 324 across all filing types
Latest filing 2025-03-12 Director's Dealing
Country GB United Kingdom
Listing IL IGP

About INTERCEDE GROUP PLC

https://www.intercede.com/

Intercede Group PLC is a cybersecurity software company specializing in digital identity and credential management. The company develops solutions that enable organizations to establish digital trust and protect against data breaches by replacing weak user credentials with stronger, phishing-resistant authentication. Its core offering is the MyID product family, a software suite designed to manage the entire lifecycle of digital identities at scale. The flagship product, MyID Credential Management System (CMS), allows for the issuance and management of high-assurance credentials using technologies like Public Key Infrastructure (PKI) and FIDO passkeys. These credentials can be deployed to various devices, including smart cards, USB tokens, and mobile phones. The MyID suite also includes solutions for Multi-Factor Authentication (MFA), secure cryptographic key storage (SecureVault), and password security management. Intercede's technology is utilized by governments and enterprises to secure access to systems and information.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official notification filed via RNS (RNS Number : 4188A) detailing share purchases by two Persons Discharging Managerial Responsibilities (PDMRs): the CEO and the CFO. The content explicitly covers 'Director/PDMR Shareholding' and includes detailed transaction tables as required by market abuse regulations. This directly corresponds to the definition of Director's Dealing (insider trades by executives).
2025-03-12 English
Continued Momentum with New Contract Orders
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 2554A' and is dated March 12, 2025. It announces 'Continued Momentum with New Contract Orders' worth over $1.37m signed during the quarter ending March 2025. The text concludes with standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This structure strongly indicates a general regulatory news announcement, which fits the definition of a Regulatory Filing (RNS), as it is not a specific financial report (like 10-K or IR), a management discussion (MDA), or an earnings release (ER), but rather a timely operational update disseminated via the regulatory news service.
2025-03-12 English
Contract Orders and Renewals
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated '08 January 2025'. It announces 'Contract Orders and Renewals' worth over $5m, detailing specific new licenses and renewals for products like MyID CMS and MyID SecureVault. It concludes by stating that this performance means the Company expects financial performance to be 'ahead of market expectations for FY25'. The presence of the RNS header, the announcement of specific business developments (orders/renewals), and the concluding statement about financial expectations strongly suggest this is a general regulatory announcement released via the RNS system, rather than a full financial report (like 10-K or IR) or a formal earnings release (ER) which typically contains summarized financial statements. Since it is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory filing category.
2025-01-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in Own Shares' in the title section and details the purchase of 13,333 ordinary shares by Intercede Group PLC as part of its share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers company share repurchases. The presence of an RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-12-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where Intercede Group PLC purchased 7,241 ordinary shares in the market as part of its share buyback programme. It details the number of shares purchased, the price, and the resulting treasury share balance. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-12-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 13,414 ordinary shares in the market as part of its share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the LSE distribution footer confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-12-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.